NEPH-ROSIS (NEPHrology in CirRhOSIS) Pilot Trial: A Trial to Treat Acute Kidney Injury Among Hospitalized Cirrhosis Patients
Conditions:   Acute Kidney Injury;   Cirrhosis;   Portal Hypertension;   Hepatorenal Syndrome;   Acute Tubule Necrosis;   Prerenal Failure Intervention:   Drug: MAP-Target Algorithm Sponsor:   University of California, San Francisco Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials

SGLT-2 Inhibitors in the Treatment of Ascites
Conditions:   Ascites Hepatic;   Cirrhosis, Liver;   Diabete Type 2 Intervention:   Drug: SGLT2 inhibitor Sponsors:   University of Palermo;   Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials

NEPH-ROSIS (NEPHrology in CirRhOSIS) Pilot Trial: A Trial to Treat Acute Kidney Injury Among Hospitalized Cirrhosis Patients
Conditions:   Acute Kidney Injury;   Cirrhosis;   Portal Hypertension;   Hepatorenal Syndrome;   Acute Tubule Necrosis;   Prerenal Failure Intervention:   Drug: MAP-Target Algorithm Sponsor:   University of California, San Francisco Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials

SGLT-2 Inhibitors in the Treatment of Ascites
Conditions:   Ascites Hepatic;   Cirrhosis, Liver;   Diabete Type 2 Intervention:   Drug: SGLT2 inhibitor Sponsors:   University of Palermo;   Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials

NEPH-ROSIS (NEPHrology in CirRhOSIS) Pilot Trial: A Trial to Treat Acute Kidney Injury Among Hospitalized Cirrhosis Patients
Conditions:   Acute Kidney Injury;   Cirrhosis;   Portal Hypertension;   Hepatorenal Syndrome;   Acute Tubule Necrosis;   Prerenal Failure Intervention:   Drug: MAP-Target Algorithm Sponsor:   University of California, San Francisco Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials

SGLT-2 Inhibitors in the Treatment of Ascites
Conditions:   Ascites Hepatic;   Cirrhosis, Liver;   Diabete Type 2 Intervention:   Drug: SGLT2 inhibitor Sponsors:   University of Palermo;   Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials

NEPH-ROSIS (NEPHrology in CirRhOSIS) Pilot Trial: A Trial to Treat Acute Kidney Injury Among Hospitalized Cirrhosis Patients
Conditions:   Acute Kidney Injury;   Cirrhosis;   Portal Hypertension;   Hepatorenal Syndrome;   Acute Tubule Necrosis;   Prerenal Failure Intervention:   Drug: MAP-Target Algorithm Sponsor:   University of California, San Francisco Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials